- Home
- Publications
- Publication Search
- Publication Details
Title
Relapsed Rhabdomyosarcoma
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 10, Issue 4, Pages 804
Publisher
MDPI AG
Online
2021-02-17
DOI
10.3390/jcm10040804
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Initial in vivo testing of a multitarget kinase inhibitor, regorafenib, by the Pediatric Preclinical Testing Consortium
- (2020) Douglas J. Harrison et al. PEDIATRIC BLOOD & CANCER
- A case of alveolar rhabdomyosarcoma showing concurrent responsive bone marrow lesions and refractory pancreatic lesions to pazopanib monotherapy
- (2020) Kiichiro Kanamitsu et al. PEDIATRIC BLOOD & CANCER
- Recent Advances and Challenges in the Treatment of Rhabdomyosarcoma
- (2020) Shinji Miwa et al. Cancers
- Defining the impact of prognostic factors at the time of relapse for nonmetastatic rhabdomyosarcoma
- (2020) Maria Carmen Affinita et al. PEDIATRIC BLOOD & CANCER
- Rhabdomyosarcoma
- (2019) Stephen X. Skapek et al. Nature Reviews Disease Primers
- Rhabdomyosarcoma diagnosed in the first year of life: Localized, metastatic, and relapsed disease. Outcome data from five trials and one registry of the Cooperative Weichteilsarkom Studiengruppe (CWS)
- (2019) Monika Sparber-Sauer et al. PEDIATRIC BLOOD & CANCER
- Risk‐based treatment for patients with first relapse or progression of rhabdomyosarcoma: A report from the Children's Oncology Group
- (2019) Leo Mascarenhas et al. CANCER
- Visualizing Engrafted Human Cancer and Therapy Responses in Immunodeficient Zebrafish
- (2019) Chuan Yan et al. CELL
- Randomized phase 2 trial of the combination of vincristine and irinotecan with or without temozolomide, in children and adults with refractory or relapsed rhabdomyosarcoma (RMS).
- (2019) Anne Sophie Defachelles et al. JOURNAL OF CLINICAL ONCOLOGY
- Preclinical rationale for entinostat in embryonal rhabdomyosarcoma
- (2019) Narendra Bharathy et al. Skeletal Muscle
- Insights into pediatric rhabdomyosarcoma research: Challenges and goals
- (2019) Marielle E. Yohe et al. PEDIATRIC BLOOD & CANCER
- Randomized Phase II Trial of Bevacizumab or Temsirolimus in Combination With Chemotherapy for First Relapse Rhabdomyosarcoma: A Report From the Children’s Oncology Group
- (2019) Leo Mascarenhas et al. JOURNAL OF CLINICAL ONCOLOGY
- Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: A report from the Children's Oncology Group
- (2019) Emily Hibbitts et al. Cancer Medicine
- Is surveillance imaging in pediatric patients treated for localized rhabdomyosarcoma useful? The European experience
- (2019) Bas Vaarwerk et al. CANCER
- Histone hyperacetylation disrupts core gene regulatory architecture in rhabdomyosarcoma
- (2019) Berkley E. Gryder et al. NATURE GENETICS
- Current and Future Treatment Strategies for Rhabdomyosarcoma
- (2019) Celine Chen et al. Frontiers in Oncology
- Functional screening of FGFR4-driven tumorigenesis identifies PI3K/mTOR inhibition as a therapeutic strategy in rhabdomyosarcoma
- (2018) Timothy McKinnon et al. ONCOGENE
- Is there a role for salvage re-irradiation in pediatric patients with locoregional recurrent rhabdomyosarcoma? Clinical outcomes from a multi-institutional cohort
- (2018) Daniel V. Wakefield et al. RADIOTHERAPY AND ONCOLOGY
- Treatment Approach and Outcomes in Infants with Localized Rhabdomyosarcoma: A Report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group
- (2018) Julie A. Bradley et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Topotecan/carboplatin regimen for refractory/recurrent rhabdomyosarcoma in children: Report from the AIEOP Soft Tissue Sarcoma Committee
- (2018) Alessia Compostella et al. TUMORI
- The addition of cixutumumab or temozolomide to intensive multiagent chemotherapy is feasible but does not improve outcome for patients with metastatic rhabdomyosarcoma
- (2018) Suman Malempati et al. CANCER
- Broad spectrum activity of the checkpoint kinase 1 inhibitor prexasertib as a single agent or chemopotentiator across a range of preclinical pediatric tumor models
- (2018) Caitlin D Lowery et al. CLINICAL CANCER RESEARCH
- Relationship of DNA methylation to mutational changes and transcriptional organization in fusion-positive and fusion-negative rhabdomyosarcoma
- (2018) Wenyue Sun et al. INTERNATIONAL JOURNAL OF CANCER
- The HDAC3–SMARCA4–miR-27a axis promotes expression of the PAX3:FOXO1 fusion oncogene in rhabdomyosarcoma
- (2018) Narendra Bharathy et al. Science Signaling
- AMORE treatment as salvage treatment in children and young adults with relapsed head-neck rhabdomyosarcoma
- (2018) Bas Vaarwerk et al. RADIOTHERAPY AND ONCOLOGY
- VIncristine, irinotecan, and temozolomide in children and adolescents with relapsed rhabdomyosarcoma
- (2017) Bhuvana A. Setty et al. PEDIATRIC BLOOD & CANCER
- Paratesticular rhabdomyosarcoma in children and adolescents-Outcome and patterns of relapse when utilizing a nonsurgical strategy for lymph node staging: Report from the International Society of Paediatric Oncology (SIOP) Malignant Mesenchymal Tumour 89 a
- (2017) Timothy Rogers et al. PEDIATRIC BLOOD & CANCER
- Consensus and controversies regarding the treatment of rhabdomyosarcoma
- (2017) Scott C. Borinstein et al. PEDIATRIC BLOOD & CANCER
- Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Patients With High-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group
- (2016) Brenda J. Weigel et al. JOURNAL OF CLINICAL ONCOLOGY
- Histology, Fusion Status, and Outcome in Alveolar Rhabdomyosarcoma With Low-Risk Clinical Features: A Report From the Children's Oncology Group
- (2016) Michael A. Arnold et al. PEDIATRIC BLOOD & CANCER
- The Role of PDGFR-β Activation in Acquired Resistance to IGF-1R Blockade in Preclinical Models of Rhabdomyosarcoma
- (2016) Christine M. Heske et al. Translational Oncology
- Relapse after localized rhabdomyosarcoma: Evaluation of the efficacy of second-line chemotherapy
- (2015) Sarah Winter et al. PEDIATRIC BLOOD & CANCER
- Does Routine Imaging of Patients for Progression or Relapse Improve Survival in Rhabdomyosarcoma?
- (2015) Jody L. Lin et al. PEDIATRIC BLOOD & CANCER
- Initial testing (stage 1) of the tubulin binding agent nanoparticle albumin-bound (nab) paclitaxel (Abraxane®) by the Pediatric Preclinical Testing Program (PPTP)
- (2015) Peter J. Houghton et al. PEDIATRIC BLOOD & CANCER
- Sarcomas
- (2015) Josephine H. HaDuong et al. PEDIATRIC CLINICS OF NORTH AMERICA
- Histone Deacetylase Inhibitors Antagonize Distinct Pathways to Suppress Tumorigenesis of Embryonal Rhabdomyosarcoma
- (2015) Terra Vleeshouwer-Neumann et al. PLoS One
- IGF-1R Inhibition Activates a YES/SFK Bypass Resistance Pathway: Rational Basis for Co-Targeting IGF-1R and Yes/SFK Kinase in Rhabdomyosarcoma
- (2015) Xiaolin Wan et al. NEOPLASIA
- A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: Results of a Sarcoma Alliance
- (2014) Alberto S. Pappo et al. CANCER
- Synergistic Activity of PARP Inhibition by Talazoparib (BMN 673) with Temozolomide in Pediatric Cancer Models in the Pediatric Preclinical Testing Program
- (2014) M. A. Smith et al. CLINICAL CANCER RESEARCH
- Dense Pattern of Embryonal Rhabdomyosarcoma, a Lesion Easily Confused With Alveolar Rhabdomyosarcoma
- (2013) Erin R. Rudzinski et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessment
- (2013) U Thiel et al. BRITISH JOURNAL OF CANCER
- Vincristine, Irinotecan, and Temozolomide for Treatment of Relapsed Alveolar Rhabdomyosarcoma
- (2013) Benjamin Avery Mixon et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Initial testing (stage 1) of eribulin, a novel tubulin binding agent, by the pediatric preclinical testing program
- (2013) E. Anders Kolb et al. PEDIATRIC BLOOD & CANCER
- Survival following disease recurrence of primary localized alveolar rhabdomyosarcoma
- (2013) Tobias M. Dantonello et al. PEDIATRIC BLOOD & CANCER
- Phase II study of vinorelbine and continuous low doses cyclophosphamide in children and young adults with a relapsed or refractory malignant solid tumour: Good tolerance profile and efficacy in rhabdomyosarcoma – A report from the Société Française des Cancers et leucémies de l’Enfant et de l’adolescent (SFCE)
- (2012) Véronique Minard-Colin et al. EUROPEAN JOURNAL OF CANCER
- Gemcitabine and docetaxel (GEMDOX) for the treatment of relapsed and refractory pediatric sarcomas
- (2012) Louis Rapkin et al. PEDIATRIC BLOOD & CANCER
- Rhabdomyosarcoma: Review of the Children's Oncology Group (COG) soft-tissue Sarcoma committee experience and rationale for current COG studies
- (2012) Suman Malempati et al. PEDIATRIC BLOOD & CANCER
- Rhabdomyosarcoma in infants younger than 1 year
- (2011) Suman Malempati et al. CANCER
- Phase I Study of Temsirolimus in Pediatric Patients With Recurrent/Refractory Solid Tumors
- (2011) Sheri L. Spunt et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Factors After Relapse in Nonmetastatic Rhabdomyosarcoma: A Nomogram to Better Define Patients Who Can Be Salvaged With Further Therapy
- (2011) Julia C. Chisholm et al. JOURNAL OF CLINICAL ONCOLOGY
- Does surgery have a role in the treatment of local relapses of non-metastatic rhabdomyosarcoma?
- (2011) Federica De Corti et al. PEDIATRIC BLOOD & CANCER
- High-Dose Chemotherapy Followed by Autologous Stem Cell Transplantation for Metastatic Rhabdomyosarcoma—A Systematic Review
- (2011) Frank Peinemann et al. PLoS One
- Randomized Phase II Window Trial of Two Schedules of Irinotecan With Vincristine in Patients With First Relapse or Progression of Rhabdomyosarcoma: A Report From the Children's Oncology Group
- (2010) Leo Mascarenhas et al. JOURNAL OF CLINICAL ONCOLOGY
- Extended phase I evaluation of vincristine, irinotecan, temozolomide, and antibiotic in children with refractory solid tumors
- (2010) René Y. McNall-Knapp et al. PEDIATRIC BLOOD & CANCER
- Molecular Classification of Rhabdomyosarcoma—Genotypic and Phenotypic Determinants of Diagnosis
- (2009) Elai Davicioni et al. AMERICAN JOURNAL OF PATHOLOGY
- Phase II evaluation of intravenous vinorelbine (Navelbine) in recurrent or refractory pediatric malignancies: A Children's Oncology Group study
- (2009) John F. Kuttesch et al. PEDIATRIC BLOOD & CANCER
- Does the time-point of relapse influence outcome in pediatric rhabdomyosarcomas?
- (2009) Adrian C. Mattke et al. PEDIATRIC BLOOD & CANCER
- Initial Patient Characteristics Can Predict Pattern and Risk of Relapse in Localized Rhabdomyosarcoma
- (2008) Tobias M. Dantonello et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Trial and Pharmacokinetic Study of Bevacizumab in Pediatric Patients With Refractory Solid Tumors: A Children's Oncology Group Study
- (2008) Julia L. Glade Bender et al. JOURNAL OF CLINICAL ONCOLOGY
- Initial testing (stage 1) of the mTOR inhibitor rapamycin by the pediatric preclinical testing program
- (2007) Peter J. Houghton et al. PEDIATRIC BLOOD & CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search